Abstract
Tumor Boards, often referred to as Multidisciplinary Team Meetings in recent literature, are an integral element of cancer care around the world today. Most generally, they involve regularly conducted meetings of healthcare providers who specialize in all aspects of cancer-related care, from diagnosis to treatment and subsequent follow-up. The attendees include, but are not limited to, oncologic surgeons, medical oncologists, radiologists, pathologists, radiation oncologists, pertinent medical specialists, research coordinators, fellows, resident staff, medical students, social workers, and case managers. They all participate in a collaborative effort not only to learn from prior patient cases and outcomes but also to provide insight on many cases prospectively. This can manifest in confirmation of a diagnosis and establishment of an encompassing treatment plan. The significance of such teamwork among medical professionals must not be understated and plays a crucial role in the present and future of cancer care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book. 2014:e461–6.
Jazieh AR. Tumor boards: Beyond the patient care conference. J Cancer Educ. 2011;26(3):405–8.
Gross GE. The role of the tumor board in a community hospital. CA Cancer J Clin. 1987;37(2):88–92.
Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN, McNeil BJ. Tumor boards and the quality of cancer care. J Natl Cancer Inst. 2013;105(2):113–21.
Nemoto K, Murakami M, Ichikawa M, Ohta I, Nomiya T, Yamakawa M, et al. Influence of a multidisciplinary cancer board on treatment decisions. Int J Clin Oncol. 2013;18(4):574–7.
Lamb BW, Sevdalis N, Benn J, Vincent C, Green JS. Multidisciplinary cancer team meeting structure and treatment decisions: A prospective correlational study. Ann Surg Oncol. 2013;20(3):715–22.
Scher KS, Tisnado DM, Rose DE, Adams JL, Ko CY, Malin JL, et al. Physician and practice characteristics influencing tumor board attendance: results from the provider survey of the Los Angeles women’s health study. J Oncol Pract. 2011;7(2):103–10.
SEER cancer statistics factsheets: bone and joint cancer. Bethesda: National Cancer Institute. http://seer.cancer.gov/statfacts/html/bones.html. Accessed 20 Nov 2015.
Moon BS. The MD Anderson cancer care series. In: Lin PP, Patel S, editors. Bone sarcoma. New York: Springer; 2013. p. 270.
Group ESESNW. Bone sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii113–23.
Marshall CL, Petersen NJ, Naik AD, Vander Velde N, Artinyan A, Albo D, et al. Implementation of a regional virtual tumor board: a prospective study evaluating feasibility and provider acceptance. Telemed J E Health. 2014;20(8):705–11.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Mulchandani, N., Maheshwari, E., Agarwal, S., Maheshwari, A.V. (2017). The Role of Tumor Boards and Referral Centers. In: Henshaw, R. (eds) Sarcoma. Springer, Cham. https://doi.org/10.1007/978-3-319-43121-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-43121-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43119-2
Online ISBN: 978-3-319-43121-5
eBook Packages: MedicineMedicine (R0)